Literature DB >> 7114869

Severe cutaneous porphyria in a 12-year-old boy: hepatoerythropoietic or symptomatic porphyria?

R S Day, P C Strauss.   

Abstract

Deforming cutaneous porphyria developed in a 12-year-old boy; the severity of his skin disease resolved spontaneously as he grew older. The clinical and biochemical aspects of this case clearly fit the descriptions in the medical literature of both hepatoerythropoietic porphyria (HEP) and infantile symptomatic porphyria (SP). Further porphyrin analyses indicated that our patient suffered from infantile SP. The lack of unquestionably unique features diagnostic for HEP raises strong doubts that it exists as a separate disease entity substantially different from infantile SP.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7114869

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  5 in total

1.  Hepatoerythropoietic porphyria misdiagnosed as child abuse: cutaneous, arthritic, and hematologic manifestations in siblings with a novel UROD mutation.

Authors:  Julie L Cantatore-Francis; Jessica Cohen-Pfeffer; Manisha Balwani; Philip Kahn; Herbert M Lazarus; Robert J Desnick; Julie V Schaffer
Journal:  Arch Dermatol       Date:  2010-05

Review 2.  Porphyria Diagnostics-Part 1: A Brief Overview of the Porphyrias.

Authors:  Vaithamanithi-Mudumbai Sadagopa Ramanujam; Karl Elmo Anderson
Journal:  Curr Protoc Hum Genet       Date:  2015-07-01

3.  Enzymatic and immunological studies of uroporphyrinogen decarboxylase in familial porphyria cutanea tarda and hepatoerythropoietic porphyria.

Authors:  H de Verneuil; C Beaumont; J C Deybach; Y Nordmann; Z Sfar; R Kastally
Journal:  Am J Hum Genet       Date:  1984-05       Impact factor: 11.025

4.  Immunochemical study of uroporphyrinogen decarboxylase in a patient with mild hepatoerythropoietic porphyria.

Authors:  H Fujita; S Sassa; A C Toback; A Kappas
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

5.  Hepatoerythropoietic porphyria precipitated by viral hepatitis.

Authors:  R J Hift; P N Meissner; G Todd
Journal:  Gut       Date:  1993-11       Impact factor: 23.059

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.